Funded Tech Companies

iVexSol

Wondering who provided funding to iVexSol? Asahi Kasei, BioLife Solutions and Bristol-Myers Squibb joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

iVexSol is a viral vector manufacturing company founded on a proprietary, next-generation, stable lentiviral vector production process that transforms the way these essential gene-delivery vehicles are made. Its technology will greatly reduce the complexity, cost, and development time of these critical reagents, thereby accelerating the development and enabling greater access to life-changing cell.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/26/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Rod Rietze

        

Chief Scientific Officer

Michael Greene

        

Company Investors

• Asahi Kasei
• BioLife Solutions
• Bristol-Myers Squibb
• Charles River Laboratories
• Casdin Capital

Browse more funded tech companies:

Ivex | Ivivi Health Sciences

Share this article

About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary